Cited 0 times in

Are we closer to achieving precision medicine for migraine treatment? A narrative review

Authors
 Keiko Ihara  ;  Francesco Casillo  ;  Ahmed Dahshan  ;  Hamit Genç  ;  Asel Jusupova  ;  Kunduz Karbozova  ;  Wonwoo Lee  ;  Yi Chia Liaw  ;  Theodoros Mavridis  ;  Hong-Kyun Park  ;  Burcu Polat  ;  Triin Helin Unt  ;  Nina Vashchenko  ;  Aisha Zhantleuova  ;  Patricia Pozo-Rosich  ;  Todd J Schwedt 
Citation
 CEPHALALGIA, Vol.44(9) : 3331024241281518, 2024-09 
Journal Title
CEPHALALGIA
ISSN
 0333-1024 
Issue Date
2024-09
MeSH
Humans ; Migraine Disorders* / drug therapy ; Migraine Disorders* / genetics ; Precision Medicine* / methods
Keywords
genomics ; headache ; imaging ; migraine ; personalized medicine ; precision medicine ; prediction ; proteomics ; treatment
Abstract
Background: The term 'precision medicine' encompasses strategies to optimize diagnosis and outcome prediction and to tailor treatment for individual patients, in consideration of their unique characteristics. The greater availability of multifaceted datasets and strategies to model such data have made precision medicine increasingly possible in recent years. Precision medicine is especially needed in the migraine field since the response to migraine treatments is not universal amongst all individuals with migraine.

Objective: To provide a narrative review describing contributions to achieving precision medicine for migraine treatment.

Methods: A search of PubMed for English language articles of human participants published from 2005 to January 2024 was conducted to identify articles that reported research contributing to precision medicine for migraine treatment. The published literature was categorized and summarized according to the type of data that were included: clinical phenotypes, genomics, proteomics, physiologic measures, and brain imaging.

Results: Published studies have investigated characteristics associated with acute and preventive treatment responses, such as nonsteroidal anti-inflammatory drugs, triptans, onabotulinumtoxinA, and anti-calcitonin gene-related peptide monoclonal antibodies, in patients with episodic or chronic migraine. There is evidence that clinical, genetic, epigenetic, proteomic, physiologic, and brain imaging features might associate with migraine treatment outcomes, although inconsistencies for such findings clearly exist.

Conclusions: The published literature suggests that there are clinical and biological features which associate with, and might be useful for predicting, migraine treatment responses. To achieve precision medicine for migraine treatment, further research is needed that validates and expands on existing findings and tests the accuracy and value of migraine treatment prediction models in clinical settings.
Full Text
https://journals.sagepub.com/doi/full/10.1177/03331024241281518
DOI
10.1177/03331024241281518
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Neurology (신경과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Wonwoo(이원우) ORCID logo https://orcid.org/0000-0002-0907-4212
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/202247
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links